Field of Science

The flame of life and death: My favorite (insufferable) chemical reaction

For me, the most astounding thing about science has always been the almost unimaginably far-reaching and profound influence that the most trite truths about the universe can have on our existence. We may think that we are in charge of our lives through our seemingly sure control of things like food, water, energy and material substances and we pride the ability of our species to stave off the worst ravages of the natural environment such as disease, starvation and environmental catastrophe. We have done such a good job of sequestering ourselves from the raw power of nature that it's all too easy to take our apparent triumph over the elements for granted. But the truth is that we are all without exception critically and pitifully beholden to a few numbers and a few laws of physics.

And a few simple chemical reactions. Which brings me to my favorite reaction for this month's blog carnival. It's a reaction so elementary that it will occupy barely a tenth of the space on a napkin or t-shirt and which could (and should) be productively explained to every human being on the planet. And it's a reaction so important that it both sustains life and very much has the potential to end it.

By now you might have guessed it. It's the humble combination of hydrocarbons with oxygen, known to all of us as combustion.

First the reaction itself which is bleedingly simple:

CnH2n+2 + (3n+1)/2 O2 → (n+1) H2O + n CO2 + Energy

That's all there is to it. There, in one line, is a statement about our world that packs at least as much information into itself as all of humanity's accumulated wisdom and follies. A hydrocarbon with a general formula CnH2n+2 reacts with oxygen to produce carbon dioxide, water and energy. That's it. You want a pithy, multifaceted (or two-faced, take your pick) take on the human condition, there you have it. While serving as the fundamental energy source for life and all the glory of evolution, it's also one that drives wars, makes enemies out of friends, divides and builds ties between nations and will without a doubt be responsible for the rise, fall and future of human civilization. Faust himself could have appeared in Goethe's dream and begged him to use this reaction in his great work.

First, the hydrocarbon itself. Humanity launched itself onto a momentous trajectory when it learnt how to dig carbon out of the ground and use it as fuel. Since then we have been biding our time for better or worse. The laws of quantum mechanics could not have supplied us with a more appropriate substance. Carbon in stable hydrocarbons is in its most reduced state, which means that you can get a bigger bang out of your buck by oxidizing it compared to almost any other substance. What billions of controlled experiments over the years in oil and natural gas refineries and coal plants have proven is that you really can't do better than carbon when it comes to balancing energy density against availability, cost, ease of handling and transportation and safety. In its solid form you can burn it to stay warm and to produce electricity, in its liquid form you can pump it into an incredibly efficient and compact gas tank. For better or worse we are probably going to be stuck with carbon as a fuel (although the energy source can wildly differ).

The second component of the chemical equation is oxygen. Carbon is very fortunate in not requiring a pure source of oxygen to burn; if it burned, say, only in an environment with 70% or more oxygen that would have been the end of modern civilization as we know it. Air is good enough for combusting carbon. In fact the element can burn under a wide range of oxygen concentrations, which is a blessing because it means that we can safely burn it in a very controlled manner. Varying the amount of oxygen can also lead to different products and can minimize the amount of soot and toxic byproducts. The marriage of carbon and oxygen is a wonderfully tolerant and productive one and we have gained enormously from this union

The right side of the combustion equation is where our troubles begin. First off, water. It may seem like a trivial, harmless byproduct of the reaction but it's precisely its benign nature that allows us to use combustion so widely. Just imagine if the combustion of carbon had produced some godforsaken toxic substance in addition to carbon dioxide as a byproduct. Making energy from combustion would then have turned into a woefully expensive activity, with special facilities required to sequester the poisonous waste. This would likely have radically altered the global production and distribution of energy and human development would have been decidedly hampered. We may then have been forced to pick alternative sources of energy early on in our history, and the face of politics, economics and technology would consequently have been very different.

Moving on we come to what's almost ubiquitously regarded as a villain these days- carbon dioxide. If carbon dioxide were as harmless as water we would live in a very different world. Sadly it's not and its properties again underscore the profound influence that a few elementary facts of physics and chemistry can have on our fate. The one property of CO2 that causes us so much agony is the fact that it's opaque to long-wavelength infrared radiation and absorbs it, thus warming the surroundings. This is not a post to discuss global warming but it's obvious to anyone not living in a cave that the issue has divided the world like no other. We still don't know for sure what it will do, either by itself or because of the actions taken by human beings from merely perceiving its effects. But whatever it is, it will profoundly alter the landscape of human civilization for better or worse. We can all collectively curse the day that the laws of physics and chemistry decided to produce carbon dioxide as a product of combustion.

Finally we come to the piece de resistance. None of this would have mattered if it weren't for the most important thing combustion produces- energy (in fact we wouldn't have been around to give a fig). In this context combustion is exactly like nuclear fission; twentieth-century history would have been very different if all uranium did was break up into two pieces. Energy production from combustion is what drives life and human greed. We stay alive by eating carbon-rich compounds - especially glucose - which are then burned in a spectacularly controlled manner to provide us with energy. The energy liberated cannot be used directly for our actions and thoughts. Instead it is used to construct devilishly clever chemical packages of ATP (adenosine triphosphate) which then serves as the energy currency.

Our bodies (and those of other creatures) are staggeringly efficient at squeezing oxidation-derived energy out of compounds like glucose; for instance in the aerobic oxidation of glucose, a single glucose molecule can generate 32 molecules of ATP. Put another way, the oxidation of a gram of glucose yields about 4 kilocalories of energy. This may not seem like a lot until we realize that the detonation of a gram of TNT yields only about 1 kilocalorie (the reason the latter seems so violent is because all the energy is liberated almost instantaneously). Clearly it is the all-important energy term in the combustion equation that has made life on earth possible. We are generously contributing to this term these days by virtue of quarter pounders and supersizing but our abuse does not diminish its importance.

The same term of course is responsible for our energy triumphs and problems. Fossil fuel plants are nowhere as efficient in extracting energy from carbon-rich hydrocarbons as our bodies, but what matters is whether they are cheap enough. It's primarily the cost of digging, transporting, storing and burning carbon that has dictated the calculus of energy. Whatever climate change does, of one thing we can be sure; we will continue to pay the cheapest price for our fuel. Considering the many advantages of carbon, it doesn't seem like anything is going to substitute its extraordinarily fortuitous properties anytime soon. We will simply have to find some way to work around, over or through its abundance and advantages.

If we think about it then, the implications of combustion for our little planet and its denizens are overwhelming and sometimes it's hard to take it all in. At such times we only need to take a deep breath and remember the last words spoken by Kevin Spacey's character from "American Beauty":

"Sometimes I feel like I'm seeing it all at once, and it's too much, my heart fills up like a balloon that's about to burst... And then I remember to relax, and stop trying to hold on to it, and then it flows through me like rain and I can't feel anything but gratitude for every single moment of my stupid little life..."

That's right. Let's have it flow through us like rain. And watch it burn.

Image source

Rookie mistakes in molecular modeling: Part 1

Molecular modeling as a general approach is no longer utilized only by experts but has reached the masses. Improved hardware and software capabilities combined with easy-to-use graphical user interfaces have enabled experimental chemists of all kinds to build models of molecules and perform relatively sophisticated calculations on them. Calculations which once required supercomputers can now be routinely done on desktops by organic, inorganic and biological chemists who can use the results to explain, support and predict chemical phenomena. In the coming years we can be confident that we will witness an increasing use of modeling techniques by experimentalists.

An unfortunate (but probably not unexpected) consequence of this ease of use is that it has also become easier to make mistakes while building molecular structures. The main source of errors arises during the translation of 2D chemical structures to their 3D counterparts using some energy minimization protocol. The apparently simple process of drawing a 3D-worthy 2D structure is trickier than it sounds and is therefore quite prone to error. Conformation which was not as important when drawing in 2D is suddenly of overriding importance and it's relatively easy to get it wrong.

As a modeler who has interacted closely with experiment, I have come across a number of rookie mistakes which I have seen myself and others make over the years. Sometimes these mistakes don't matter too much for the final result but sometimes they can completely change it. So I thought I would make a short list of easy-to-avoid errors which may provide checks on modeling structures. In part 1 I will describe mistakes commonly seen during the simple building of structures. Part 2 will deal with interactions with experimentalists.

1. Getting the ionization state wrong: I put this rookie mistake at the top because it's remarkable how many times I have seen even experienced modelers make it. Always remember; amines are protonated at physiological pH while carboxylic acids are deprotonated. The reason why getting this right is important is because it can completely change results from protocols like docking. Just think of the difference a protonated vs unprotonated carboxylate makes for binding to a protein. Also, many modeling algorithms use force fields which are dominated by electrostatic interactions; the wrong protonation state can therefore make a world of difference. A corollary of the ionization state problem results when replacing atoms. For instance you may have a protonated amine which you then want to turn into an alcohol by replacing the N with a O. Unfortunately the atom does change but not the ionization state, and you end up with a weird positively charged doubly bonded oxygen. On a related note, it goes without saying that you shouldn't charge up inappropriate atoms such as those which are conjugated to aromatic systems. The best way to overcome these issues is to simply display charges for all heteroatoms in your final structure.

2. Getting the stereochemistry wrong: The CIP rules were taught to us because they really matter. Here's a typical stereochemical mistake: You construct a structure in 2D and come across a stereocenter. You may even build that stereocenter with the right absolute (R or S) stereochemistry. And then you attach something else to that center and forget to recheck the stereochemistry which may have changed because of the change in CIP priority. The simplest way to make sure about stereochemistry is to always have the program display all absolute stereochemistry for the final structure.

2. Forgetting basic conformational rules: This mistake is most commonly made when converting a 2D structure into a 3D structure. The problem is that when you build a 2D structure, your placement of bonds and angles is somewhat ad hoc based on the rather random way in which you are conveniently rotating and viewing the structure. When you then suddenly convert 2D to 3D, you may end up with axial substituents on six-membered rings, syn-pentane or eclipsing interactions between substituents, funky substructures like non-planar aromatic rings resulting from strain or in the worst cases, even boats for cyclohexanes. Here's another common pitfall: You may try to close a ring by building an unrealistic long bond between two initially separated atoms, thinking that when you then minimize this structure the program will take care of the bond by shortening it to its standard length. This usually happens, but in the process some other parts of your molecule gets messed up. Again, judicious inspection can avoid most of these issues.

3. Cis and trans: The process of building unrealistic bonds between distant atoms and then simply minimizing a structure that I just mentioned can sometimes result in amide bonds becoming cis and this is important enough to be listed as a separate point. This is also a common consequence of importing 2D files in SDF format (which lack hydrogens) and asking a program to add hydrogens. The same thing can happen with double bonds.

4. Forgetting basic chemistry: This mistake has more to do with forgetting basic rules of bonding and chemistry than with modeling. Occasionally you may do things like exceeding the allowed valency of an atom, putting a double bond at a bridgehead carbon (violating Bredt's rule), generating antiaromatic rings, forgetting Baldwin's rules for ring closure, building a vinyl amine or a geminal amino alcohol...and generally creating all sorts of unstable and "impossible" molecules. The problem is that your program won't always raise red flags notifying you about these errors so you need to remember your chemistry and make sure you don't recommend some wacky molecules to make to the synthetic chemist (one of the constant sources of friction between experimentalists and modelers arises from the latter forgetting what's synthetically feasible and stable).

Ultimately, the path to a well-constructed molecule simply depends on being vigilant and judiciously checking your final structure. Remember the well-worn adage; computers don't know any chemistry whatever and they are only as good as the code that goes into them. Nothing can trump a sound knowledge of basic chemical principles.

In which creationists' understanding of amyloid appears...tangled

The biophysicist David Eisenberg of UCLA recently published a paper in which his group surveyed what they called the "amylome", the set of all possible proteins that can potentially form the deadly amyloid aggregate implicated in diseases like Alzheimer's. I haven't read the whole paper yet and will describe it in another post but it has some very intriguing conclusions (see the Nature News piece).

Eisenberg's group end up finding common segments possessing amyloid-forming propensity in pretty much every protein, given the right conditions. Not surprisingly, these segments are mostly kept tucked inside protein cores; if exposed the proteins are refolded with chaperones or eliminated as non-functional. But this ties in with Chris Dobson's work which I described in a recent post. Dobson's most recent paper seemed to conclude that amyloid is actually the most thermodynamically stable state of a protein, with "normal" protein states being metastable.

All this is fascinating stuff, but you can always trust creationists to put an anti-evolutionist spin on almost any scientific funding. Someone named Cornelius Hunter asserts on his blog that the fact that the most stable state of proteins seems to be amyloid and that most real proteins don't actually exist in this state seems to be a kind of miracle or at the very least indicates the enormous difficulties attendant in creating complex biomolecular structures.

Mr. Hunter seems to be indulging in a common fallacy, that of assuming that evolution somehow tends to an ideal. This is just not the way the process works. Considering the stringent constraints and time in which evolution has to work, it can only explore the available space of solutions and not the entire possible space. It can never achieve the best possible result in solution space, only one that is good enough under the given circumstances. I don't know if it's really that hard to understand or whether creationists like Mr. Hunter want to deliberately obfuscate the issue. Evolution can only work on what's already available; it can only mix and match existing motifs, and what exists need not be perfect at all. As an aside, this function of evolution reminds me of the concept of "satisficing" or "bounded rationality" in economics; lacking perfect knowledge of all solutions and unlimited time, economic actors like us can only pick solutions optimal within current constraints, not "global" maximums on the solution landscape.

There's therefore no reason to believe that biological evolution should create the most thermodynamically stable state of a protein. Creating a state that is functionally relevant is enough, even if it's thermodynamically metastable. In fact one can even make an argument that a thermodynamically superstable state might lead to an evolutionary dead end since it will be hard to tinker with. Given such constraints it's indeed impressive that evolution creates enzymes speeding up chemical reactions by twelve orders of magnitude, but even these enzymes are few and probably not the best possible in all of enzyme space.


So yes, the fact that it's amyloid and not the normal state of proteins that is the most thermodynamically stable one is fascinating, but in no way does this present a great challenge to evolution. In fact it reinforces evolution's essential character, to hunker down and make do as well as it can under the given circumstances. Don't we all?

2011 Nobel Prizes


So it's that time of the year again, the time when just like Richard Feynman and Paul Dirac, three select individuals get to mull over whether they will incur more publicity by accepting the Nobel Prize or rejecting it.

Predicting the Nobel Prizes gets easier every year ((I said
predicting, not getting your predictions right) since there's very little you can add in the previous year's list, although there are a few changes; the Plucky Palladists can now happily be struck off the list. As before, I am dividing categories into 'easy', and 'difficult' and assigning pros and cons to every prediction.

The easy ones are those regarding discoveries whose importance is (now) ‘obvious’; these discoveries inevitably make it to lists everywhere each year and the palladists clearly fell into this category. The difficult predictions would either be discoveries which have been predicted by few others or ones that that are ‘non-obvious’. But what exactly is a discovery of ‘non-obvious’ importance? Well, one of the criteria in my mind for a ‘non-obvious’ Nobel Prize is one that is awarded to an individual for general achievements in a field rather than for specific discoveries, much like the lifetime achievement Academy Awards given out to men and women with canes. Such predictions are somewhat harder to make simply because fields are honored by prizes much less frequently than specific discoveries.

When predicting the Nobel prize it's also prudent to be cognizant of discoveries whose recognition makes you go "Of course! That's obvious". Prizes for the charge-coupled device (CCD) (2009) integrated chip (2000) and in-vitro fertilization (2010) fall into this category.

Anyway, here's the N-list

2. Computational chemistry and biochemistry (Difficult):
Pros: Computational chemistry as a field has not been recognized since 1999 so the time seems due. One obvious candidate would be Martin Karplus. Another would be Norman Allinger, the pioneer of molecular mechanics.
Cons: This would definitely be a lifetime achievement award. Karplus did do the first MD simulation of a protein ever but that by itself wouldn’t command a Nobel Prize. The other question is regarding what field exactly the prize would honor. If it’s specifically applications to biochemistry, then Karplus alone would probably suffice. But if the prize is for computational methods and applications in general, then others would also have to be considered, most notably Allinger but perhaps also Ken Houk who has been foremost in applying such methods to organic chemistry. Another interesting candidate is David Baker whose program Rosetta has really produced some fantastic results in predicting protein structure and folding. It even spawned a cool game. But the field is probably too new for a prize and would have to be further validated.

3. Chemical biology and chemical genetics (Easy)
Another favorite for years, with Stuart Schreiber and Peter Schultz being touted as leading candidates.
Pros: The general field has had a significant impact on basic and applied science
Cons: This again would be more of a lifetime achievement award which is rare. Plus, there are several individuals in recent years (Cravatt, Bertozzi, Shokat) who have contributed to the field. It may make some sense to award Schreiber a ‘pioneer’ award for raising ‘awareness’ but that’s sure going to make a lot of people unhappy. Also, a prize for chemical biology might be yet another one whose time has just passed.

4. Single-molecule spectroscopy (Easy)
Pros: The field has obviously matured and is now a powerful tool for exploring everything from nanoparticles to DNA. It’s been touted as a candidate for years. The frontrunners seem to be W E Moerner and M Orrit, although Richard Zare has also been floated often.
Cons: The only con I can think of is that the field might yet be too new for a prize

5. Electron transfer in biological systems (Easy)
Pros: Another field which has matured and has been well-validated. Gray and Bard seem to be leading candidates.

Among other fields, I don’t really see a prize for the long lionized birth pill and Carl Djerassi; although we might yet be surprised, the time just seems to have passed. Then there are fields which seem too immature for the prize; among these are molecular machines (Stoddart et al.) and solar cells (Gratzel).

MEDICINE:

1. Nuclear receptors (Easy)
Pros: The importance of these proteins is unquestioned. Most predictors seem to converge on the names of Chambon/Jensen/Evans.

2. Chaperones: (Easy)
Arthur Horwich and Franz-Ulrich Hartl just won this year's Lasker Award for their discovery of chaperones. Their names have been high on the list for some time now.
Pros: Clearly important. Chaperones are not only important for studying protein folding on a basic level but in the last few years the malfunctioning of chaperones such as heat-shock proteins has been shown to be very relevant to diseases like cancer.
Cons: Too early? Probably not.

3. Statins (Difficult)
Akira Endo’s name does not seem to have been discussed much. Endo discovered the first statin. Although this particular compound was not a blockbuster drug, since then statins have revolutionized the treatment of heart disease.
Pros: The “importance” as described in Nobel’s will is obvious since statins have become the best-selling drugs in history. It also might be a nice statement to award the prize to the discovery of a drug for a change. Who knows, it might even boost the image of a much maligned pharmaceutical industry...
Cons: The committee is not really known for awarding actual drug discovery. Precedents like Alexander Fleming (antibiotics), James Black (beta blockers, antiulcer drugs) and Gertrude Elion (immunosuppresants, anticancer agents) exist but are far and few in between. On the other hand this fact might make a prize for drug discovery overdue.

4. Genomics (Difficult)
A lot of people say that Venter should get the prize, but it’s not clear exactly for what. Not for the human genome, which others would deserve too. If a prize was to be given out for synthetic biology, it’s almost certainly premature. Venter’s synthetic organisms from last year may rule the world, but for now we humans still prevail. On the other hand, a possible prize for genomics may rope in people like Carruthers and Hood who pioneered methods for DNA synthesis.

5. DNA fingerprinting and synthesis (Easy)
Now this seems to me to be very much a field from the "obvious" category. The impact of DNA fingerprinting and Western and Southern Blots on pure and applied science- everything from discovering new drugs to hunting down serial killers- is at least as big as the prizeworthy PCR. I think the committee would be doing itself a favor by honoring Jeffreys, Stark, Burnette and Southern.

And while we are on DNA, I think it's also worth throwing in Marvin Caruthers whose technique for DNA synthesis really transformed the field. In fact it would be nice to award a dual kind of prize for DNA- for both synthesis and diagnosis.

Cons: Picking three might be tricky.

6. Stem Cells (Easy)
This seems to be yet another favorite. McCulloch and Till are often listed. Unfortunately McCullough died earlier this year so it would be a little unfair to award just Till. However such a thing is not unprecedented. For example, the psychologist Daniel Kahneman shared the 2002 Economics Nobel Prize with Vernon L. Smith. Left out was his long-time collaborator Amos Tversky who had died in the 90s; it's pretty much regarded as a given that Tversky would have shared the prize had he been alive.
Pros: Surely one of the most important biological discoveries of the last 50 years, promising fascinating advances in human health and disease.
Cons: Politically controversial (although we hope the committee can rise above this). Plus, a 2007 Nobel was awarded for work on embryonic stem cells using gene targeting strategies so there’s a recent precedent.

7. Membrane vesicle trafficking (Easy)
Rothman and Schekman
Pros: Clearly important. The last trafficking/transport prize was given out in 1999 (Blobel) so another one is due and Rothman and Schekman seem to be the most likely canidates. Plus, they have already won the Lasker Award which in the past has been a good indicator of the Nobel.

8. GPCR structures (Difficult)
A commenter reminded me of this. When the latest GPCR structure (the first one of a GPCR bound to a G protein) came out I remember remarking that Kobilka, Stevens and Palczewski are probably up for a prize sometime.
Palczewski solved the first structure of rhodopsin and Stevens and Kobilka have been churning out structure after important structure over the last decade, including the first structure of an active receptor along with several medicinally important ones including the dopamine D3 and CXCR4 receptors. These feats are definitely technical tour de forces.
Pros: GPCR's are clearly important for basic and applied science, especially drug discovery where 30% of drugs already target these proteins.
Cons: Too early.

PHYSICS

I am not a physicist
But if I were
I would dare
To shout from my lair
“Give Hawking and Penrose the Prize!”
For being rock stars of humungous size

Also, Anton Zeilinger, John Clauser and Alain Aspect deserve it for bringing the unbelievably weird phenomenon of quantum entanglement to the masses. Zeilinger's book "Dance of the Photons" presents an informative and revealing account of this work

I have also always wondered whether non-linear dynamics and chaos deserves a prize. The proliferation and importance of the field certainly seems to warrant one; the problem is that there are way too many deserving recipients (and Mandelbrot is dead).

Other predictions: Canine Ed, Sam@EverydayScientist

Thoughts on personalized medicine


This is a piece I had written up for the annual report of this year's Lindau Meeting of Nobel Laureates. The final version had to be significantly edited because of space limitations so I thought I would post the full version here.

The future of personalized medicine

In this year’s Lindau meeting, the Israeli biochemist Ciechanover expressed great hope for the future of personalised medicine, an age in which medical treatments are customized and tailored to individual patients based on their specific kind disease.

In some ways personalised medicine is already here. Over centuries of medical progress, astute doctors have fully recognized the diversity of patients who are suffering from what appears to be the same disease. Based on their rudimentary knowledge of disease processes, empirical data and experience, physicians would then prescribe different combinations of medicines for different patients. But in the absence of detailed knowledge of disease at the genetic and molecular level, this kind of approach was naturally subjective; it continued to rely on extensive personal experience and ad hoc interpretations of incompletely documented empirical data.

This approach saw a paradigm shift in the latter half of the twentieth century as our knowledge of DNA and genetics revealed to us the rich diversity and uniqueness of individual genomes. Concomitantly, our knowledge of the molecular basis of disease led us to recognize molecular determinants unique to every individual. We are already taking advantage of this knowledge and harnessing it to personalize therapy.

Take the case of the anticancer drug temozolomide for instance. Temozolomide is prescribed for patients with a particularly pernicious form of brain cancer with poor prognosis. The drug belongs to a category of compounds called alkylating agents, a common class of anticancer drugs in which a reactive chemical group is transferred onto DNA in cancer cells, rendering them incapable of efficient cell division and causing their death. The problem is that because of its key role in sustaining life processes, DNA division is tightly controlled. Any kind of modification of the kind caused by temozolomide is treated as DNA damage and- for good reason- life has evolved multiple mechanisms to reverse such damage. In this case the body produces an enzyme that strips DNA of the reactive functionality attached by the drug. Thus the body unwillingly helps cancer cells by reversing the drug’s action. The understanding of this mechanism has led doctors to personalize temozolomide treatment only for individuals who have low levels of the drug-resisting enzyme. For other patients that produce high levels of the enzyme, temozolomide will unfortunately not be effective and doctors will have to turn to other drugs.

We will undoubtedly witness the proliferation of such advances in personalizing individual treatments in the future. But what appears to be an even more promising approach is to start at the source, at the fundamental genomic sequences that dictate the phenotypical changes associated with enzymes and proteins. The deciphering of the human genome has opened up exciting and promising new avenues for mapping differences in individual genomes and harnessing these differences in drug discovery. The most important strategy has been to compare genomes of individuals for single nucleotide polymorphisms (SNPs) which are changes in single base pairs in the DNA sequence. In fact much of the genetic variation between individuals and populations arises from these single nucleotide changes. SNPs have been of enormous value in tracing genetic diseases and generally categorizing variations in our species. They are typically utilised in genome-wide association studies in which the genomes of members of a certain homogeneous population with and without a disease are compared. Knowing the differences can enable scientists to pinpoint genetic markers responsible for the disease. These genetic markers can then be linked to phenotypes like enzyme overproduction or deficiency that are more directly related to the disease. In addition SNPs are unusually stable and remain constant between generations, providing scientists with a relatively time-invariant handle to study genetic disorders. One of the most notable instances of using SNPs to determine propensity toward disease involves the so-called ApoE gene in Alzheimer’s disease. Two SNPs in this gene lead to three alleles- E2, E3 and E4. Each individual inherits one maternal and one paternal copy of the ApoE gene and there is now solid evidence that the inheritance of the E4 allele leads to a greatly increased risk of Alzheimer’s disease.

In the long run, SNP’s may provide the foundation for much of personalised medicine. This is because SNPs also often dictate individuals’ propensity toward drugs, pathogens and vaccines. Thus in an ideal scenario, one might be able to predict a patient’s response to a whole battery of drugs using knowledge of specific SNPs associated with his or her disease.

Unfortunately this ideal scenario may be much farther than imagined. For one thing, we have still only scraped the surface of all possible SNPs, and there are already an estimated three million out there. But more importantly, the difference between knowing all the SNPs and knowing their causal connections to various diseases is almost like the difference between a list of all human beings on the planet on one hand and everything about their lives on the other; their professions, origins, hobbies, political views, family lives. Knowing the former is far from understanding the latter.

In this sense the problem with SNPs illustrates the problems with all of personalised medicine. In fact it’s a problem that plagues scientific research in general, and that’s the dilemma of separating correlation from causation. The problem is even more acute in a complex biological system like a human being where the ratio of extraneous unrelated correlations to genuinely causative factors is especially high. Simply knowing the SNP variations between a healthy and diseased individual is very different from being able to pinpoint the SNP that is directly connected to the disease. The situation is made exponentially more complex by the fact that these putative determinants usually act in combination with each other. Thus one has to now account not only for the effect of an individual SNP but also for the differential effects of its combination with other SNPs. And as if this complexity were not enough, there’s also the fact that many SNPs occur in non-coding regions of the human genome, leading to even bigger questions about their exact relevance. Sophisticated computers and statistical methods are enabling us to sort through this jungle of data, but as of now the data itself clearly outnumbers our ability to intelligently analyse it. We need to become far more capable at distinguishing signal from noise if we are to translate genetic understanding into practical therapeutic strategies.

In addition, while a certain kind of SNP may be able to determine disease tendency, there are also many false positives and negatives. Only a small percentage of SNPs are typically linked to a condition, especially when it comes to complex conditions like cancer, diabetes and psychological disorders. Many SNPs may simply be surrogate SNPs that have little to do with the disease themselves but which have come along for the ride with other SNPs. It is a difficult task to say the least to separate the wheat from the chaff and hone in on the few SNPs that are truly serving as disease determinants or markers. In such cases it is instructive to borrow from the example of temozolomide and remember that ultimately we will be able to untangle cause and effect only by looking at the molecular level interaction of drugs and biomolecules. No amount of data sequencing and analysis can really be a substitute for a robust study designed to directly demonstrate the role of a particular enzyme or protein in the etiology of a disease. It’s also worth noting that such studies have always benefited from the tools of classical biochemistry and pharmacology, and thus practitioners of these arts will continue to stand on an equal footing with the new genomics experts and computational biologists in unraveling the implications of genetic differences.

Finally, there’s the all-pervasive question of nature versus nurture. Along with genomics, one of the most important advances of the last decade has been the development of epigenetics. Epigenetics refers to changes in the genome that are induced by the environment and not hard-coded in the DNA sequence. An example includes the environmentally stimulated silencing or activation of genes by certain classes of enzymes. Epigenetic factors are now known to be responsible for a variety of processes in diseases and health. Some of these factors can even operate in the fetal stage and influence physiological responses in later life. While epigenetics has revealed a fascinating new layer of biological control and has much to teach us, it also adds another layer of complexity to the determination of individual responses to therapy. We have a long way to go before we can perfect the capability to clearly distinguish genetic from epigenetic factors as signposts for individualized therapy.

The future of personalised medicine is therefore both highly exciting as well as extremely challenging. There is much promise to be had in mapping the subtle genetic differences that make us react differently to diseases and their cures, but we will also have to be exceedingly careful in not leading ourselves astray with incomplete data, absence of causation and confirmation bias. It is a tough, but ultimately rewarding problem which will lead to both fundamental understanding and new medical advances. It deserves our attention in every way.

Image source

Are chemists much more secretive and obsessive than physicists?

Derek said it on his blog today and I have been saying it for some time. The physics community did itself and others a great service by floating ArXiv, which has become the standard venue for publication of premium physics papers focused on theory and computation. As Derek asks, why isn't there such a free service started by chemists for their community?

I concur, and a related question I have concerns being able to look at citations. The APS website (which hosts the JACS-equivalent physics journal Physical Review among others) allows readers to view the number of citations for all its papers and therefore allows us to sort papers by citations. No such feature exists for ACS or Wiley chemistry journals; as far as I know one has to log in to a paid site like Web of Science to be able to view citations.

This leads me to a question of psychology.
Are chemists much more secretive and obsessive about their data and results compared to physicists? Are they much more self-conscious about revealing the impact (or lack thereof) of their publications to the public? Does some vestigial culture of secrecy going back to the alchemists' creed still linger in our minds?

It could not have to do with the status of the field since many branches of physics are as cutting edge as fields of chemistry. The first explanation that comes to my mind has to do with the color green. It's pretty clear that compared to physics, many fields of chemistry such as medicinal chemistry and materials science have money-making written on them. Unlike most physicists, chemists can patent their molecules and make money from them to a much greater extent. If this is the case, then a control group might be that of engineers. Is a reluctance to make publications or citations easily available also prevalent among the engineering community?

Yet such money-making results constitute only one part of the chemical literature. What about the several academic chemistry papers that have no tangible commercial potential? Why not make them available for free and make their citations available? I don't know the right explanation for this habit, but simple inertia and lack of vigorous discussion and initiative seem to clearly play a role. I do hope it's not because of a statistically significant difference between chemists and physicists that causes the former to hoard results.

The way I see it, the chemistry community clearly should borrow a page from the physicists. Firstly, certain kinds of chemistry papers (just like theoretical papers on ArXiv) need to be made available for free. Secondly, we all deserve a look at citation data which should not be so inaccessible and expensive. If science is supposed to be a community enterprise, this seems to be the least we can do.

Why biology (and chemistry) is not physics

In the Wall Street Journal, the physics writer Jeremy Bernstein has a fine review of a new joint biography by Gino Segre of George Gamow and Max Delbruck named "Ordinary Geniuses" which I just started reading.
Gamow and Delbruck were not as well known as some of their more famous peers but as Segre demonstrates, both made very important contributions to cosmology and molecular biology through direct experimentation and theorizing as well as by inspiring others' research. In addition the two were colorful and engaging characters which makes the book a pleasure to read.
But it was the first paragraph of the review that really caught my eye:

Some sciences are more unruly than others. Here's a parable to illustrate what I mean. Imagine that when the first life form appeared there was a superintelligent freak. If this freak had had a complete knowledge of the laws of physics, what could it have predicted? Quite a lot. All atomic nuclei consist of neutrons and protons, and the number of protons determines each element's chemical nature. Knowing this, the freak could have predicted all the elements that could possibly exist, along with their respective characteristics. Suppose that it also knew all the laws of biology, including the "central dogma," which explains how genes are expressed as proteins. Even so, it could not have predicted the existence of giraffes, nor even the fact that my brother and I share only half our genes. Both of these are evolutionary accidents. If it had not been for random mutation there would be no giraffes, and my brother and I might have shared all our genes, as male bumblebees do. Biology is not like physics.
This paragraph succinctly pretty much nails down the fundamental limitations of physics-based reductionism and it's a point that applies to chemistry as well. It's a very important point. The problem is that reductionism will never be able to account for the role of historical contingency and accident. Even if an all-powerful being could account for all biological scenarios emerging from an initial state of the universe, it could never tell us why one particular scenario is preferred over others. As Bernstein says, evolutionary accidents by definition cannot be predicted from starting conditions because they depend on chance and opportunity.
In addition function can never be uniquely derived from reductionism even if structure is. For instance in his book "Reinventing the Sacred", the complexity theorist Stuart Kauffman makes a powerful argument that even if one could derive the structure of the human heart from string theory in principle, string theory would never tell us that its most important function is to pump blood. The function of biological organs arose as an adaptive consequence of the countless unpredictable constraints that molded them during evolution. In addition the evolution of both structure and function was a mix-and-match process that depended as much on chance encounters as on strict adaptation. All this can never be captured in a reductionist worldview.
The same principle applies to chemistry. For instance the supreme being would never have been able to tell us why there are only twenty amino acids, why there are alpha amino acids instead of beta or gamma versions (which have extra carbon atoms), why amino acid stereochemistry is L while sugar stereochemistry is D, why there are four DNA bases with their unique structures, why nature chose phosphates (although Frank Westheimer comes close), why a given protein folds into only one unique functional structure, why water is the only solvent known to sustain life, and in general why the myriad small and large molecules of life are what they are. In retrospect of course one could provide several arguments for the existence of these molecules based on stability, function and structure but there is no way to predict these parameters prospectively.
The problem is that there is nothing in the nature of these molecules that dictates that their presence should have been uniquely determined. For instance we now know from synthetic studies that beta and gamma amino acids can also fold into the kind of helices and (less so) sheets that are ubiquitous for alpha amino acids. In addition these "higher order" amino acids provide extra handles for functional group attachment (see top figure). Yet for some reason they were discarded during evolution. Why? We could come up with several arguments. 

For instance because of their floppiness, maybe the higher order versions had to pay an unacceptable entropic penalty that could not compensate for their folding propensity. Or maybe the Strecker reaction that is thought to produce alpha amino acids could never be superseded by other chemical reactions for forming beta amino acids. Or perhaps alpha amino acids shield hydrophobic side chains much better than their longer chain counterparts. Cogent reasons, all of these, and yet I am sure we could find an equal number of arguments against alpha amino acids if we searched hard enough. The ultimate failure to find an explanation for the existence of alpha amino acids is a powerful reminder of the importance that chance and circumstance played in the evolution of both biomolecules as well as living organisms.
This role of contingency and accident is one of the most important reasons why the reduction of chemistry and biology to physics won't work. In addition as I have described before, reductionism cannot account for variety in chemistry. Yet another reason why chemistry and biology are not physics.

No ordinary geniuses


John Cockcroft and George Gamow rejoicing on the resolution of a thorny problem, ca. 1930. (Source)

The mathematician Mark Kac classified geniuses into two kinds. "Ordinary" geniuses were those who accomplished a lot, but who gave you the feeling that you too could be as successful if you worked hard enough. The other kind of genius was the "magician", a person whose thought processes for all intents and purposes were hidden from you and who made you feel that you could not catch up no matter how hard you tried.

Kac's distinction does apply, but it's also a little unfair to "ordinary" geniuses who happen to include many Nobel laureates. These ordinary geniuses may not have been Newton, Darwin or Einstein but collectively they were responsible for the underpinnings of most of modern science. In his book the physicist and author Gino Segre brings two such ordinary geniuses- George Gamow and Max Delbruck- to life. Gamow and Delbruck are not as famous in the public eye as some of their contemporaries like Einstein, Dirac or Feynman but as Segre marvelously demonstrates, they were founding fathers of two of the twentieth and twenty-first century's most important fields- cosmology and molecular biology. Segre does a great job of explaining the two men's discoveries, lives and working philosophies and also paints a vivid portrait of the important times which they lived in.

Both started as physicists, Gamow in Russia and Delbruck in Germany. Both grew up amidst war and civil strife and ended up emigrating to the United States as refugees from communism and fascism; Gamow and his wife had to literally flee from the Soviet Union to escape Stalin's yoke. Both were lucky to grow up during the heyday of modern physics when quantum mechanics was being created in Germany, England and Denmark. Gamow made an early name for himself by pioneering nuclear physics while Delbruck floundered as a physicist for some time before finding his niche in biology. The two met in Niels Bohr's famous institute in Copenhagen where they discovered their common interests and struck up a lifelong friendship.

One of the biggest virtues of the book is in bringing out the distinctive working style of the two scientists. This style was marked by independence of thought, an unwillingness to follow the beaten track and a relentless enthusiasm for staking out new grounds. Both men were mavericks who, in Gamow's words, were always looking for the next "pioneering thing". Inspired by Bohr, Delbruck turned to molecular biology when the subject did not even formally exist. Thinking of a basic experimental unit in biology akin to the hydrogen atom in physics which would shed light on key biological processes and be amenable to experiment, Delbruck picked bacteriophages- viruses which attack bacteria. Along with another emigre, the Italian Salvador Luria, he performed foundational studies that demonstrated the fundamental role of mutations and their effect on bacterial phenotypes; one of their most important experiments proved that mutations that arise in response to selection are preexisting and not induced by the selection agent. With a few such elegant studies Delbruck and Luria connected genetics to bacteriology. Since then microbial genetics has been the source of some of our most important insights into heredity, genetic engineering and medicine. The phages whose importance they highlighted continue to be tools of incredible utility in our search for genetic mechanisms and new medical therapies. Along with Alfred Hershey, Delbruck and Luria were awarded the Nobel Prize for their work in 1969.

Delbruck and Luria at Cold Spring Harbor Laboratory, 1953 (Source)

While Delbruck was tinkering with viruses, Gamow turned to nuclear and astrophysics when the fields were not too popular. He was the first to explain the so-called bizarre "tunnel effect" in alpha decay, a quintessentially quantum mechanical phenomenon which allows particles to surmount energy barriers which are classically unsurmountable. The tunnel effect underlies many important processes in physics and chemistry, from nuclear decay to the workings of enzymes. But Gamow's main contribution was in formulating the Big Bang Theory which is at the foundation of modern cosmology. He thought longer and harder about the origin of the universe than most of his contemporaries and he did this long before the physicists Arno Penzias and Robert Wilson discovered the cosmic microwave background radiation emanating from the Big Bang, which Gamow had actually predicted. It is a pity that Gamow did not share the Nobel Prize with them.

Later in life, Gamow became a world-renowned popularizer of science. His popular physics books inspired many children to study science and his "Mr. Tompkins" series brought the bizarre mysteries of quantum mechanics to the masses. I myself remember being greatly inspired as a child by the wit and insight in these volumes. As if these contributions were not enough, Gamow later turned to molecular biology and collaborated with the founders of molecular biology including James Watson and Francis Crick. He supplied some of the early thinking about the genetic code and even though the details of his ideas were not correct, he stimulated others to think in the right direction. Delbruck himself was inspired by Gamow's ideas. In his later life he became a mentor to a whole generation of biologists, mostly at Caltech and at Cold Spring Harbor Laboratory, who founded the study of genomics. Delbruck contributed as much through his mentorship as through his research.

In addition as the book showcases, the two were eminently interesting characters. Delbruck was a man who spoke his mind, not afraid to poke, probe and question until he got to the truth. Gamow's colorful personality has become the stuff of legend. He was a practical joker who used to constantly play pranks on his colleagues and insert jokes even in technical scientific papers. Just one anecdote will suffice; in a bar, some of Gamow's friends once bribed a waitress to startle him by asking him if he was the British physicist Fred Hoyle, the Big Bang Theory's staunchest opponent. Without missing a beat Gamow replied, "Now now, don't throw Hoyle over troubled waters." Gamow and Delbruck showed us not just how to do great science but how to have fun doing it.

Max Delbruck's and George Gamow's ideas essentially underlie some of today's most important questions in biology and cosmology. For all of Kac's categorization of geniuses, there is no doubt that the two were extraordinary scientists. We will all continue to stand on their shoulders.

The barrier to amyloid formation is kinetic, not thermodynamic

One of the questions I have pondered in the past is why the functional form of a protein should correspond to its most thermodynamically stable structure. Although this assumption is built into almost all experimental and theoretical studies of protein folding, it is not at all obvious since one may imagine other forms which could have improved stability. For instance, two protein forms may differ in the presence of a hydrogen bond or two. Based on the location and connectivity of these bonds, sometimes this slight rearrangement can cause a radical change in function, but there's no good reason why it should in the general case.

The answer however is most obvious in case of amyloid, that endlessly intriguing protein form that is implicated in so many devastating neurological disorders. Amyloid is a very stable state is often highly resistant to temperature, pH and high salt conditions. It's fair to ask how stable or unstable it is with respect to functional, soluble forms of the same protein.

To answer this question, a team led by Christopher Dobson who is a world expert on amyloid performed a series of thermodynamic measurements on a diverse group of proteins in which they measured the free energy differences between the soluble and the amyloid state. The proteins included everything from the Aß protein found in Alzheimer's disease to human lysozyme and insulin. The finding was that the free energy differences (ranging from about 3 kcal/mol to 6 kcal/mol) are not terribly dependent on the exact sequence, an observation which would be consistent with the striking recently uncovered fact that amyloid formation can be induced in almost any protein independent of its sequence. In fact the free energy difference seemed to depend more on the length and seemed to be optimal for a length of 100 residues for which the amyloid form was most stable. The difference also sharply tipped away from amyloid for increasing lengths.

This observation seems to suggest that one consequence of evolving larger proteins might be steer them away from the amyloid state and is consistent with the fact that almost all amyloid proteins have relatively short lengths (for instance, the Alzheimer's disease amyloid protein Aß has a length of roughly 40 residues). The propensity toward amyloid formation also depended on the concentration and the authors derived an limiting concentration beyond which amyloid formation would be rapid. This is again not surprising since the concentration-dependence of the process has also been demonstrated.

The real surprise came when they compared these limiting concentrations of the protein to the corresponding physiological concentrations of the same proteins in plasma. Remarkably, they found that in almost every case the physiological concentration was higher than that required to achieve amyloid formation. Thus
the observations clearly indicate that for many key proteins, the amyloid state is thermodynamically more stable than the native, functional state. To put it bluntly, many nicely folded and soluble proteins are actually metastable. Now, since native proteins don't constantly form amyloid and kill us all, it's clear that the barrier to amyloid formation must be kinetic. Intriguingly, the authors speculate that these barriers can be overcome when organisms are exposed to stress, mutations or aging.

This is a pretty intriguing study and seems to underscore the belief that at least for some proteins, the folded functional state is not the most stable. However in light of what we know about evolution, this should not be too surprising. Stability is just one of many factors to be optimized during natural selection and there is no reason to assume that evolution would always act to maximize this parameter at the cost of all others. It's worth always keeping in mind that evolution cannot afford to aim for the ideal but instead has to make do with what it has.

The other question in my mind is why in spite of these barriers existing in case of so many proteins like lysozyme, insulin etc. are they regularly overcome only in the case of Aß (1-42) and a select few others. Based on the speculation in the paper, this could be because these proteins are exposed to particularly harsh conditions that force them to climb past the kinetic barrier and settle into the amyloid valley of thermodynamic comfort and physiological woe.

Among many such conditions could very well be bacterial infections. A few years back I advanced a hypothesis about amyloid formation being a defense against viral and bacterial infection mediated through the production of free radicals. A kinetic barrier-surpassing mechanism of the kind speculated here might well be what allows these proteins to achieve the transition, killing the bacteria but ironically harming their owner in the process. In the context of the present study, I think there continue to be a lot of opportunities to investigate the possible infection-induced conversion of normal proteins to their amyloid form.

Hopefully someone will do the experiment.


Baldwin, A., Knowles, T., Tartaglia, G., Fitzpatrick, A., Devlin, G., Shammas, S., Waudby, C., Mossuto, M., Meehan, S., Gras, S., Christodoulou, J., Anthony-Cahill, S., Barker, P., Vendruscolo, M., & Dobson, C. (2011). Metastability of Native Proteins and the Phenomenon of Amyloid Formation Journal of the American Chemical Society DOI: 10.1021/ja2017703

Why conduct reactions at low temperature?

The other day I was talking to a synthetic chemist friend about conducting reactions at low temperature and I realized that there is another reason for doing this that is not always appreciated by beginning organic chemistry students. Most students think that the primary purpose of low-temperature reactions is to stop runaway exothermic reactions from getting out of hand and to tame explosive reagents. While this is a perfectly good reason, there is another reason connected to stereochemistry which occasionally necessitates these reactions.

Remember the all important thermodynamic relation ∆G = ∆H - T∆S and recall that life and laboratory chemistry are both games played within a 3 kcal/mol window. In this case the relevant equation would be the Arrhenius equation and the relevant free energy would be the free energy of activation (∆G††). Thus even a 1 kcal/mol energy difference between two transition states can favor the product corresponding to the lower energy TS by a substantial account; for instance you only need a 1.8 kcal/mol energy difference to effect a greater than 95% yield of the more stable species. This principle applies to everything, including conformers, stereoisomers and constitutional isomers. But the important variable for our discussion is the temperature T and it's clear that a lower temperature will affect the free energy favorably.

And that is precisely why it becomes so important in stereoselective reactions. If you are dealing with two diastereometric transition states resulting from attack of a chiral reagent on two enantiomers for instance, you only need a difference of 1.13 kcal/mol to generate a diastereomeric ratio of 95:5. But this phenomenon becomes even more pronounced at -78 degrees celsius which is the temperature of a standard liquid N2 acetone/dry ice bath. For instance, if you conduct a reaction giving you a 95:5 diastereomeric ratio at -78 degrees,
the same reaction done at 23 degrees will give you only a 85:15 diastereomeric ratio. And if you look at the energy you need at 23 degrees to overcome that low ratio and bump it to 95:5, it's only 0.58 kcal/mol.

It's incredible to realize how so much of life and chemistry are governed by startlingly small differences in energy between large numbers. But there you have it; a very good reason to lower the temperature of your next aldol condensation to get better stereoselectivity. Make sure to emphasize that to your curious undergrad the next time he/she asks a question about low temperature reactions.